Two Doses of GHB04L1 for Pandemic Influenza Prophylaxis in Healthy Adults
Clinical trial NCT03745274 · COMPLETED
Trial details
- NCT number
- NCT03745274
- Sponsor
- AVIR Green Hills Biotechnology AG
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-19
- Primary completion
- 2009-05-27
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.